Search for: "Mylan Pharmaceuticals" Results 201 - 220 of 738
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Sep 2016, 10:42 am by Jim Caton
What galls us most about Mylan Pharmaceuticals’ inflating the price of the EpiPen to bursting is the stark image it presents of the fix we’re in. [read post]
16 Oct 2015, 8:00 pm by John Ehrett
The petition of the day is: Mylan Pharmaceuticals Inc. v. [read post]
16 Jun 2010, 4:06 pm by Seth
Plaintiff Bernice Gainer brought a product liability claim against Mylan Pharmaceuticals arising from alleged injuries from the generic version of the drug, Dilantin, and its active ingredient Phenytoin. [read post]
27 Dec 2013, 4:55 am by Gene Quinn
FTC Settles with Mylan over Agila Acquisition. [read post]
6 Oct 2023, 10:45 am by Alec Pronk
Court of Appeals for the Federal Circuit (CAFC) issues two precedential patent opinions; X Social Media sues Elon Musk’s social media platform X for copyright infringement; and the PTAB grants Mylan Pharmaceutical’s petition for an inter partes review on the validity of Novo Nordisk’s Ozempic and Wegovy patents. [read post]
6 Oct 2023, 10:45 am by Alec Pronk
Court of Appeals for the Federal Circuit (CAFC) issues two precedential patent opinions; X Social Media sues Elon Musk’s social media platform X for copyright infringement; and the PTAB grants Mylan Pharmaceutical’s petition for an inter partes review on the validity of Novo Nordisk’s Ozempic and Wegovy patents. [read post]
14 Nov 2016, 2:01 pm by Susanna Leighton
As previously reported, Mylan Inc., the pharmaceutical manufacturer of the life-saving EpiPen, misclassified their brand name drug as generic for years, thus deceiving and effectively defrauding governmentally-funded insurance providers Medicare and Medicaid, resulting in millions of dollars in overpayments by taxpayers, all in an effort to save themselves money prior to hiking the price of The post EpiFail: Gov’t Knew EpiPen Was Misclassified in 2009 appeared first on Legal… [read post]
14 Jun 2018, 3:45 am by Steve Brachmann
Mylan Pharmaceuticals, a case appealed from the Patent Trial and Appeal Board (PTAB) which asks the appeals court to determine whether tribal sovereign immunity can be asserted to terminate inter partes review (IPR) proceedings at the PTAB. [read post]
27 Jan 2010, 9:20 pm by Walter Olson
District Judge Joseph Goodwin plans to punish lawyers who filed worthless claims against Mylan Pharmaceuticals and Actavis Totowa. [read post]
17 May 2018, 2:24 pm by Sabrina I. Pacifici
The list of 52 drugs are made by some of the biggest pharmaceutical companies including Novartis, Pfizer, Mylan, and Valeant “FDA is committed – among other things – to addressing and improving transparency about this and other gaming tactics that delay the generic competition Congress intended,” the agency said on Thursday. [read post]
9 Sep 2011, 6:13 am by Ed Wallis
MYLAN FALSE CLAIMS ACT ALLEGEDLY MERITLESS As reported by the Pittsburgh Business Times, a False Claims Act lawsuit against Mylan Pharmaceuticals is allegedly “meritless” per the company. [read post]
17 Oct 2007, 10:00 pm
I have just found out from the Generic Pharmaceuticals and IP blog that Teva has now sued 16 companies in relation to its Carvedilol process patents.The 16 defendants are: Zentiva; Mylan; Taro Pharmaceuticals; Lupin; Moehs Iberica; Urquima; Orchid; Wanbury;Z hejiang  Huahai; USV Ltd.; Cadila; Ranbaxy; Dr. [read post]